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Highlights
 Intrahepatic Vd2neg cd T cells are clonally focussed and
feature private TCR rearrangements.
 Effector CD27lo/neg Vd1+ T cells are enriched in liver, but
naïve CD27hi cells are absent.
 A subset of Vd1+ T cells is distinct from those in blood and
may be liver tissue resident.
 Liver Vd1+ cd T cells are polyfunctional and respond to both
TCR and innate stimuli.Stuart Hunter,Carrie R.Willcox,
Martin S. Davey, ...,Dmitriy M. Chudakov,
Ye H. Oo,Benjamin E.Willcox
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Lay summary
cd T cells are frequently enriched in many
solid tissues, however the immunobiol-
ogy of such tissue-associated subsets in
humans has remained unclear. We show
that intrahepatic cd T cells are enriched
for clonally expanded effector T cells,
whereas naïve cd T cells are largely
excluded. Moreover, whereas a distinct
proportion of circulating T cell clonotypes
was present in both the liver tissue and
peripheral blood, a functionally and
clonotypically distinct population of
liver-resident cd T cells was also evident.
Our findings suggest that factors trigger-
ing cd T cell clonal selection and differ-
entiation, such as infection, can drive
enrichment of cd T cells into liver tissue,
allowing the development of functionally
distinct tissue-restricted memory popula-
tions specialised in local hepatic immuno-
surveillance.Molecular and Cell BiologyJ. Hepatol. 2018, 69, 654–665
licenses/by/4.0/).
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Molecular and Cell BiologyHuman liver infiltrating cd T c
expanded circulating and t
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Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia; 4
European Institute of Technology, Masaryk University, Brno, Czech Rep
Russia; 7University Hospital of Birmingha
Background & Aims:cd T cells comprise a substantial propor-
tion of tissue-associated lymphocytes. However, our current
understanding of human cd T cells is primarily based on periph-
eral blood subsets, while the immunobiology of tissue-
associated subsets remains largely unclear. Therefore, we aimed
to elucidate the T cell receptor (TCR) diversity, immunopheno-
type and function of cd T cells in the human liver.
Methods:We characterised the TCR repertoire, immunopheno-
type and function of human liver infiltrating cd T cells, by TCR
sequencing analysis, flow cytometry, in situ hybridisation and
immunohistochemistry. We focussed on the predominant
tissue-associated Vd2 cd subset, which is implicated in liver
immunopathology.
Results: Intrahepatic Vd2 cd T cells were highly clonally
focussed, with single expanded clonotypes featuring complex,
private TCR rearrangements frequently dominating the com-
partment. Such T cells were predominantly CD27lo/ effector
lymphocytes, whereas naïve CD27hi, TCR-diverse populations
present in matched blood were generally absent in the liver.
Furthermore, while a CD45RAhi Vd2 cd effector subset present
in both liver and peripheral blood contained overlapping TCR
clonotypes, the liver Vd2 cd T cell pool also included a pheno-
typically distinct CD45RAlo effector compartment that was
enriched for expression of the tissue tropism marker CD69,
the hepatic homing chemokine receptors CXCR3 and CXCR6,
and liver-restricted TCR clonotypes, suggestive of intrahepatic
tissue residency. Liver infiltrating Vd2 cd cells were capable
of polyfunctional cytokine secretion, and unlike peripheral
blood subsets, were responsive to both TCR and innate stimuli.Keywords: Gamma delta T cells; T cell receptor; Liver immune surveillance; Liver-
resident T cells; Human liver; Immunological memory.
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Conclusion: These findings suggest that the ability of Vd2 cd T
cells to undergo clonotypic expansion and differentiation is cru-
cial in permitting access to solid tissues, such as the liver, which
results in functionally distinct peripheral and liver-resident
memory cd T cell subsets. They also highlight the inherent func-
tional plasticity within the Vd2 cd T cell compartment and pro-
vide information that could be used for the design of cellular
therapies that suppress liver inflammation or combat liver
cancer.
Lay summary:cd T cells are frequently enriched in many solid
tissues, however the immunobiology of such tissue-associated
subsets in humans has remained unclear. We show that intra-
hepatic cd T cells are enriched for clonally expanded effector T
cells, whereas naïve cd T cells are largely excluded. Moreover,
whereas a distinct proportion of circulating T cell clonotypes
was present in both the liver tissue and peripheral blood, a func-
tionally and clonotypically distinct population of liver-resident
cd T cells was also evident. Our findings suggest that factors trig-
gering cd T cell clonal selection and differentiation, such as infec-
tion, can drive enrichment of cd T cells into liver tissue, allowing
the development of functionally distinct tissue-restricted mem-
ory populations specialised in local hepatic immunosurveillance.
 2018 European Association for the Study of the Liver. Published by
Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
cd T cells are unconventional lymphocytes enriched in solid tis-
sues, where they are thought to play critical roles in immuno-
surveillance.1 Studies of mouse tissue-associated cd subsets
suggest cd T cell function can be predominantly innate-like,
involving semi-invariant T cell subsets that enable fast response
kinetics without a requirement for clonal selection and differen-
tiation.2–5 This role may allow for rapid ‘lymphoid stress
surveillance’, limiting damage to host tissues in the face of
microbial or non-microbial challenges, prior to full activation
of adaptive immunity.4,6 As such, cd T cells may critically
complement the contributions of tissue-resident ab subsets,
which provide an augmented adaptive response to infections
re-encountered at body surfaces,7 potentially explaining the
retention of cd T cells alongside the ab T cell and B cell lineage
over 450 million years of vertebrate evolution.8018 vol. 69 j 654–665
In contrast, the paradigms underlying human cd T cell
immunobiology are far from clear. In humans, the peripheral
blood is dominated by the Vd2+/Vc9+ T cell subset, polyclonally
activated by bacterial9 and endogenous phospho-antigens,10
arguably conforming to an innate-like paradigm.11 In contrast,
human solid tissues are enriched for Vd2 cd T cells, of which
the Vd1+ subset is the most prevalent. It is far less clear if this
dominant human tissue-associated subset also adopts an
innate-like biology. Indeed, Vd2 T cells have been linked to
recognition of a diverse range of ligands including to date
Endothelial Protein C Receptor,12 CD1 molecules,13 Annexin-
A2,14 and even phycoerythrin.15 Moreover, recent data have
provided strong evidence that Vd1+ cells display an unconven-
tional adaptive biology, undergoing clonal selection and differ-
entiation from a naïve T cell receptor (TCR)-diverse precursor
pool,16 with viral infection one trigger driving expansion.17
However, such studies have focussed on the subset of Vd2 cd
T cells that are retained in peripheral blood. To date, the
immunobiology of human tissue-associated cd T cells remains
relatively unstudied, despite the Vd2 T cell subset representing
a considerable proportion of the total T cell infiltration in many
human solid tissues, including gut,2 lung18 and liver.19
To shed light on the function of tissue-associated cd T cells
and how this relates to peripheral subsets, we characterised
human intrahepatic Vd2 T cells. The liver is a site of consider-
able blood flow, receiving 75% of the total blood in the body
every 2 h, with a third of this originating directly from the
antigen-rich gut via the portal vein. In addition to providing a
generally immunosuppressive microenvironment to facilitate
tolerization of T cells toward non-pathogenic antigens present
in the portal blood flow, the liver is also home to a large popu-
lation of innate lymphoid cells, including natural killer (NK)
cells, invariant natural killer T (iNKT) cells, mucosal associated
invariant T (MAIT) cells20 and cd T cells,19 in addition to CD8+
cytotoxic T cells.21 This enrichment is believed to balance the
need for tolerization with a requirement for rapid identification
and elimination of potentially harmful pathogenic entities, for
example via pathogen associated molecular pattern receptors
and semi-invariant T cell populations.22 To shed light on the
immunobiology of cd T cells in this context we exploited next
generation sequencing (NGS) approaches, allowing us to probe
the TCR repertoire, in parallel with immunophenotype, and
function.
Our study is the first to define the interconnected clonotypic,
phenotypic and functional features of human tissue-associated
cd T cells. The findings suggest that the liver selectively retains
Vd2 T cells that are clonally expanded and adopt an effector
phenotype, and which include a subset containing liver-
restricted clonotypes that is phenotypically and functionally
distinct from those present in peripheral blood.
(Local Research Ethics Committee reference No. 06/Q2708/11).
Unless otherwise stated (see Fig. 1), all diseased liver tissue
analysed was from HCV/HBV-negative donors, and were non-
cancerous. Normal liver tissue donors had no known prior his-
tory of liver disease or HCV/HBV infection. All diseased livers
were Child C decompensated. Adult peripheral blood was
obtained from consenting healthy donors (protocol approved
by the NRES Committee West Midlands ethical board; REC
reference 14/WM/1254).
T cell isolation, culture and activation
Human liver infiltrating lymphocytes were isolated from fresh
liver tissue as described previously.20 A whole slice of liver
was processed, thereby reducing any effects of heterogeneous
disease localisation. Briefly, explanted liver tissue was diced
into 5 mm3 cubes, washed with Phosphate Buffered Saline
(PBS), and then homogenised in a Seward stomacher 400 circu-
lator (260 rpm, 5 min). The homogenate was filtered through
fine (63 lm) mesh (John Staniar and Co, Manchester, UK) and
the lymphocytes were isolated by density gradient separation
using Lympholyte (VH Bio, Gateshead, UK) at 800g for 20
min. The lymphocyte layer was collected and washed with
PBS. Cell viability was assessed by trypan blue exclusion.
Peripheral blood mononuclear cells (PBMCs) were isolated from
heparinised venous blood by lymphoprep (Stem Cell Tech-
nologies) density gradient centrifugation as per the manufac-
turer’s instructions. The cell culture medium used throughout
this study was RPMI-1640 medium (Invitrogen) supplemented
with 2 mM L-glutamine, 1% sodium pyruvate, 50 lg/ml peni-
cillin/streptomycin (Invitrogen) and 10% foetal calf serum
(Sigma).
Antibodies and flow cytometry
For total and single-cell sorting of Vd2 and Vd1+ cd T popula-
tions, PBMC were labelled with anti-CD3 (UCHT1; BioLegend),
TCR cd (BW242/412), TCR Vd2 (123R3) or TCR Vd1 (REA173);
all Miltenyi, CD27 (M-T271), CD45RA (HI100); BioLegend, and
populations were sorted on a MoFlo Astrios (Beckman Coulter)
or ARIA III Fusion (BD). For repertoire analysis, Vd2 T cell pop-
ulations were sorted directly into RNAlater (Sigma). For pheno-
typic analysis, freshly isolated or frozen PBMCs, or cultured cells
were labelled with Zombie Aqua viability dye (BioLegend), and
then subsequently stained for cell surface antigens with anti-
bodies directed against CD3 BV421 (UCHT-1, 1:100), CD8
BV650 (SK1; 1:200), CD45RA PeCy7 (HI100; 1:200), CD27 PE/
Dazzle 594 (M-T271; 1:200), CCR7 AF647 (G043H7; 1:100),
CD62L APC-Cy7 (DREG-56; 1:100), CD28 PE (28.2; 1:80), CD16
PE-Cy7 (3G8; 1:100), CD69 BV605 (FN50; 1:100), CD25 BV421
(2A3; 1:100), CD54 BV421 (HA58; 1:100), TCR Vd2 PE (B6;
1:100), TCR cd PE Cy7 (B1; 1:100), TCR ab PE (IP26; 1:50),
CXCR3 PE (G025H7); all BioLegend. CXCR6 PE (56811/FAB699P;
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Ethical approval and samples
Explanted diseased liver tissue and matched blood were
obtained from patients who underwent liver transplantation
for end-stage liver diseases including primary sclerosing
cholangitis (PSC), primary biliary cholangitis (PBC), alcoholic
liver disease (ALD), non-alcoholic steatohepatitis (NASH), hep-
atitis C virus (HCV) and hepatitis B virus (HBV) (Local Research
Ethics Committee reference No. 98/CA5192) or normal liver
samples from donor liver tissue surplus to clinical requirementsJournal of Hepatology 21:20) from R&D Systems. Mouse anti-human CX3CR1-PE (2A9–
1; 1:20), CD69 PE (FN50; 1:50) from Immunotools. Mouse
anti-human CD127 APC (IM1980U; 1:20), TCR cd PE Cy7
(IMMU510; 1:200), TCR Vd3 FITC and TCR Vc9 PE Cy5
(IMMU360; 1:400); Beckman Coulter. TCR Vd1 PE (TS8.2;
1:100); Fisher Scientific. TCR Vd1 PE and FITC (REA173; 1:100)
and TCR Vd2 APC (123R3; 1:200); Miltenyi Biotec. For intracel-
lular staining, after surface antibody staining, cells were fixed in
Foxp3/Transcription factor fix/perm buffer (eBioscience) and
stained in permeabilization buffer (eBioscience) with antibodies
directed against Granzyme A FITC (CBO9; 1:100), Granzyme B018 vol. 69 j 654–665 655
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Research Article Molecular and Cell BiologyAPC (GB11; 1:100) and Perforin BV421 (B-D48; 1:80); all BioLe-
gend. For intracellular cytokine staining, antibodies used were
interferon-c (IFNc) BV421 (340449; 1:200), tumour necrosis
factor alpha (TNFa) PE (554512; 1:200); BD Pharmingen, Cells
were acquired on a CyAn ADP (Beckman Coulter), LSR II or LSR
Fortessa X20 (BD) and data analysed with FlowJo V10.2
(TreeStar) or Summit 4.3 software (Dako Cytomation).
Immunohistochemistry and in situ hybridisation
Immunohistochemistry was performed using formalin fixed
paraffin embedded (FFPE) sections using standard approaches.
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Fig. 1. Normal liver parenchyma is enriched for cd T cells. (A) Comparison
diseased (n = 62) liver tissue (left) and in CD3+ T cells identified by IHC in no
hepatitis (n = 12) liver tissue (right). (B) Representative staining for CD3+ (lef
viewed at 40 magnification. (C) Densities of CD3+ and cd TCR+ cells in nor
proportion of CD3+ T cells identified by IHC in parenchymal and portal areas of
proportion of CD3+ T cells identified by flow cytometry in normal (n = 15) and d
of CD3+ T cells identified by flow cytometry in normal (n = 15) and diseased
proportions in cd TCR+ cells identified by flow cytometry from normal (n = 15
proportions in Vd2 cells from liver cell suspensions (n = 16). (I) Comparison
CMV+ donors (n = 6) from diseased livers. Error bars indicate mean ± SEM; da
p >0.05, **p <0.01, ***p <0.001 and ****p <0.0001. ALD, alcoholic liver dise
immunohistochemistry; NASH, non-alcoholic steatohepatitis; PBC, primary bi
figure appears in colour on the web.)656 Journal of Hepatology 2al
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n.s. *In summary, sections were de-paraffinized, endogenous perox-
idase activity was quenched using 0.3% hydrogen peroxide
(Sigma Aldrich) in methanol for 20 min, and antigen retrieval
carried out, involving boiling sections in 1% EDTA solution for
15 min. After washing and blocking steps, sections were
incubated for 1 h in primary antibody (goat polyclonal – anti-
human pan-VcVd (50 lg/ ml, A-20, Santa Cruz Biotechnology,
Santa Cruz, USA) or rabbit polyclonal – anti-human CD3
(2 lg/ml, ab5690, Abcam, Cambridge, UK) or relevant IgG1 iso-
type control) diluted in PBS. After washing, sections were incu-
bated with HRP-linked anti-goat or anti-rabbit secondary
al (n = 21), PSC (n = 13), PBC (n = 13), ALD (n = 12), NASH (n = 12) and viral
and cd TCR+ (right) cells on sequential FFPE sections from NASH liver tissue
al (n = 21) and diseased (n = 62) liver tissue. (D) Comparison of the cd TCR+
ormal (n = 15) and diseased (n = 30) liver tissue. (E) Comparison of the cd TCR+
eased (n = 42) liver cell suspensions. (F) Comparison of the cd TCR+ proportion
er cell suspensions of various aetiologies. (G) Comparison of Vd2+ and Vd2
nd diseased (n = 42) liver cell suspensions. (H) Comparison of Vd1+ and Vd1
Vd2+ (left) and Vd1+ (right) proportion of CD3+ T cells in CMV (n = 11) and
analysed by Kruskal-Wallis ANOVA with Dunn’s post-test comparisons, n.s.
se; CMV, cytomegalovirus; FFPE, formalin-fixed paraffin embedded; IHC,
ry cholangitis; PSC, primary sclerosing cholangitis; TCR, T cell receptor. (This018 vol. 69 j 654–665
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OF HEPATOLOGYantibody (Vector Labs Laboratories) for 30 min at room temper-
ature. Following washing, sections were developed using
ImmPACTTM DAB reagent (Vector Laboratories). Excess DAB
was then removed by rinsing and sections were counterstained
with Mayer’s haematoxylin solution (Leica Biosystems). Once
dry, slides were mounted using DPX (Cellpath, Newtown Powys,
UK) and imaged on a Zeiss Axioskop 40 Microscope. Regions of
parenchymal and portal tract tissue were identified and num-
bers of CD3+ or cd-TCR+ cells were counted per region identi-
fied, with five high power fields, selected at random, scored
for each section.
For in situ hybridisation, TCR chain-specific localisation of
gamma delta TCR+ cells was performed using two protocols,
either the ViewRNATM ISH Tissue 2-Plex Assay developed by Affy-
metrix and performedmanually, or the RNAscope 2.5 LS Duplex
Assay (ACD. For both protocols, liver slices were cut and imme-
diately fixed in formalin for 24–48 h prior to being embedded in
paraffin and mounted. Immediately after which the assay slides
were baked at 60 C for 1 h to immobilise the sections.
TCR repertoire analysis
RNA was purified from sorted cells (intrahepatic Vd2 T cells:
8,000–50,000 cells) protected in RNAlater (Sigma Aldrich) using
an RNAmicro plus kit (Qiagen) according to the manufacturer’s
instructions. For high throughput deep sequencing of cd TCRs,
we used amplicon rescued multiplex (ARM)-PCR and a MiSeq
(illumina) next generation sequencer to analyse all sorted
Vd2 T cell populations. Following initial first-round RT-PCR
using high concentrations of gene-specific primers, universal
primers were used for the exponential phase of amplification
(Patent: WO2009137255A2), allowing deep, quantitative and
non-biased amplification of TCRc and TCRd sequences. All cDNA
synthesis, amplification, NGS library preparation and sequenc-
ing were performed by iRepertoire, Inc. (Huntsville, USA).
Single-cell TCR sequencing
PBMCs were labelled as described above and Vd1+ T cells were
single-cell sorted directly into individual wells in a 96 well plate
containing 2 ll of Superscript VILO cDNA synthesis kit reaction
mix (ThermoFisher) containing 0.1% Triton X-100, and incubated
according to manufacturer’s instructions. TCRc and TCRd cDNAs
were amplified by two rounds of nested PCR using GoTaqmaster-
mix (Promega) and primers for or Vd1, CAAGCCCAGTCATCAG-
TATCC (external) and CAACTTCCCAGCAAAGAGATG (internal);
for Cd GCAGGATCAAACTCTGTTATCTTC (external) and TCCTTC
ACCAGACAAGCGAC (internal); for Vd3, GGCACGCTGTGTGACAAA
(external) and CTGCTCTGCACTTACGACACTG (internal); for
Vc1–8 CTGGTACCTACACCAGGAGGGGAAGG (external) and TGT
GTTGGAATCAGGAVTCAG (internal); for Vc9 AGAGAGACCTGGT
GAAGTCATACA (external) and GGTGGATAGGATACCTGAAACG
(internal) and for Cc CTGACGATACATCTGTGTTCTTTG (external)
and AATCGTGTTGCTCTTCTTTTCTT (internal). PCR products were
separated on 1.2% agarose gels, and products of successful
reactions were incubated with ExoSAP-IT PCR cleanup enzyme
(Affymetrix) before sequencing with BigDye Terminator v3.1
(Applied Biosystems) following manufacturer’s instructions
and running on an ABI 3730 capillary sequencer (Functional
Genomics Facility, University of Birmingham).
TCR repertoire data analysis
Sequences data was error corrected and V, D and J gene usage
and complementarity-determining region 3 (CDR3) sequencesJournal of Hepatology 2were identified and assigned, and tree maps generated using
iRweb tools (iRepertoire, Inc, Huntsville, AL, USA). Tree maps
show each unique CDR3 as a coloured rectangle, the size of each
rectangle corresponds to each CDR3s abundance within the
repertoire and the positioning is determined by the V region
usage. For more detailed analysis and error correction of the
TCR repertoire, datasets were processed using the MiXCR soft-
ware package to further correct for PCR and sequencing errors.
Diversity metrics, clonotype overlap and gene usage were plot-
ted in R, by VDJTools.
TCR sequence analyses
The CDR3 length was defined as the number of amino acids
between the second cysteine of the V region and the phenylala-
nine of the J region, according to IMGT. N and P nucleotides
were identified using the IMGT Junction Analysis tool.
Statistical analysis
Tabulated data were analysed in Graphpad PRISM 7 (Graphpad
Software Inc). Each data set was assessed for normality using
Shapiro-Wilk normality test. Differences between columns were
analysed by two-tailed Student’s t tests for normally distributed
data and Mann-Whitney for non-parametric data. Differences
between groups were analysed using one-way ANOVA with
Tukey’s post-tests for normally distributed data or with
Kruskal-Wallis with Tukey’s post-tests for non-parametric data
and RM two-way ANOVA with Tukey’s post-tests was used
when comparing groups with independent variables. ⁄p <0.05,
⁄⁄p <0.01, ⁄⁄⁄p <0.001 and ⁄⁄⁄⁄p <0.0001.
Data availability
The sequence data that support the findings of this study have
been deposited in the NIH NCBI sequence read archive database
with the primary accession code SRP113556 and SRP096009, for
cd TCR repertoires. For more detailed metadata relating to indi-
vidual samples please contact the authors.
For further details regarding the materials used, please refer
to the CTAT table and Supplementary information.
Results
Human Vd2 cd T cell populations are reportedly tissue tropic
in nature, with enrichment of this compartment previously
highlighted in diseased human gut23 and liver.19 We used
immunohistochemistry (IHC) analysis to assess the infiltration
and localisation of liver cd T cells. Firstly, cd T cells were a sig-
nificantly enriched proportion of infiltrating CD3+ T cells in nor-
mal livers compared with livers explanted from patients with
chronic liver disease (Fig. 1A). Furthermore, we noted the
majority of the infiltrating CD3+ T cells were localised to portal
areas; however, analysis of sequentially stained sections from
normal tissue revealed a high proportion of parenchyma-
associated CD3+ T cells were cd TCR+ (Fig. 1B). Importantly,
while a significant increase in infiltrating CD3+ T cells was
observed in diseased tissue, cd T cell numbers did not signifi-
cantly change, suggesting that disease drives an increased infil-
tration of total CD3+ T cells but not cd TCR+ cell infiltration from
the periphery (Fig. 1B, C, Fig. S1A). Further analysis of sequen-
tially stained sections from explanted livers confirmed that cd
TCR+ cells were also preferentially associated with the liver par-
enchyma (Fig. 1D, Fig. S1B). We then examined the TCRd chain
expression of liver infiltrating cd T cell populations by flow018 vol. 69 j 654–665 657
cytometry, in homogenised single-cell suspensions of liver tis-
sue from human explanted livers (Fig. S1C). Consistent with
our IHC data, a significantly higher proportion of the CD3+ T cell
compartment was comprised of cd T cells in healthy liver tissue
compared with disease tissue (Fig. 1E-F), of which the majority
were Vd2 (Fig. 1G), a direct inversion of the predominance of
Vd2+ T cells in the peripheral blood.24,16 Moreover, the majority
of the Vd2 compartment was made up of Vd1+ cd T cells
(Fig. 1H, Fig. S1D), with the remainder comprised of other unde-
fined Vd chains. Disease aetiology had no observed impact on
this observation (Fig. S1E). Consistent with pan-cd T cell IHC,
infiltration of Vd1+ cd T cells into liver parenchyma was demon-
strated using IHC and in situ hybridisation; again, IHC staining of
sequential sections suggested a high proportion of parenchyma-
associated CD3+ T cells were Vd1+ (Fig. S1F). Of note, Vd1+ cd T
cells were significantly enriched as a proportion of intrahepatic
T cells in diseased cytomegalovirus (CMV)+ liver donors com-
pared with diseased CMV donors, while Vd2+ T cells were not
(Fig. 1I).
We next assessed the TCR repertoire of enriched populations
of Vd2 cd T cells from both healthy and diseased liver tissue by
amplicon rescued multiplex (ARM)-PCR and deep sequencing
(Fig. S2A). Tree plot and clonotype analysis of Vd2 TCR reper-
toires indicated that both healthy and diseased liver tissue
was generally dominated by a small number of highly prevalent
clonotypes (Fig. 2A–C), with the 10 most prevalent CDR3
sequences accounting for >40% of TCRc and TCRd sequences in
9 and 8 out of 10 samples, respectively, and one dominant
clone representing >50% in 2 of the 10 TCRc and TCRd samples
(Fig. 2B-C). Comparison with D75 values obtained from adult
and cord blood Vd1+ TCR repertoires placed liver Vd2 TCR
repertoires in a comparable range with other highly focussed
cd TCR repertoires (Fig. 2D). Furthermore, when measuring
the number of unique clonotypes detected in the first 105
CDR3 sequences obtained in each sample, an alternative
measure of TCR diversity, liver samples displayed a significantly
less diverse repertoire than blood cd TCR repertoires (Fig. S2B).
Comparison of Chao1 diversity metrics revealed no difference in
the diversity of clonotypes between healthy and diseased liver
TCR repertoires (Fig. S2C). Consistent with a broadly similar
TCR repertoire in healthy and diseased tissue, comparison of
normalised CDR3 lengths from healthy and diseased samples
yielded no discernible difference (Fig. S2D). Previous studies
have highlighted that peripheral blood Vd2 TCRc repertoires
contain few shared sequences.16,17 We found that liver Vd2
TCRc repertoires were in general more private than blood

evidence of clonal expansion, initially using accumulated
frequency curves to measure the 10 most prevalent clonotypes
across all samples (Fig. S2F). These analyses provided evidence
for clonal dominance in both liver Vd1+ and Vd3+ TCR
repertoires, similar to clonotypically focussed peripheral blood
Vd1+ TCR repertoires but different from unfocussed cord
blood Vd1+ TCR repertoires (Fig. S2F).
This distinctive clonal dominance was unequivocally con-
firmed by sorting single intrahepatic Vd1+ and Vd3+ T cells
and performing single-cell TCR sequencing. This approach high-
lighted that intrahepatic Vd1+ and Vd3+ (Fig. 3) T cell popula-
tions were composed of a small number of dominant
clonotypes, using a variety of functional Vc and Jc gene seg-
ments. We also confirmed that concurrent clonal focussing
can occur in both Vd1+ and Vd3+ TCR repertoires in the same
donors (Fig. S3A). Moreover, analysis of CDR3d sequences
revealed substantial complexity. As in peripheral blood, CDR3d1
were long, frequently using two diversity (D) gene segments
and containing extensive non-templated nucleotide (nt) addi-
tions (Table. S1). CDR3d3 sequences were generally shorter than
CDR3d1 sequences and contained fewer non-templated nt
(Table. S2; Fig. S3B), though there was no evidence of CDR3d3
length restriction, in contrast to CDR3c9 sequences in
Vc9+/Vd2+ T cells.16 These data highlight the private nature of
expanded clonotypes in intrahepatic Vd2 TCR repertoires and
the broad range of Vc chains that they collectively utilise.
We next assessed the relationship between peripheral blood
and intrahepatic Vd1+ TCRs in the same individuals. Flow
cytometry analysis of these matched samples indicated the
enrichment of cd T cells in the liver (Fig. 4A), which occurred
alongside the previously noted enrichment of CD8+ ab T cells
(Fig. 4B).25–27 Moreover, while Vd1+ T cells were specifically
enriched there was an overall reduction in the proportion of
infiltrating Vd2+ T cells in the liver compared to the blood
(Fig. 4C). Peripheral blood Vd1+ T cells comprise both clonotyp-
ically focussed effector and separate TCR-unfocussed naïve sub-
compartments, which can be delineated based on distinct
CD27lo/ CD45RA+ and CD27hi CD45RA+/ expression patterns,
respectively.16 We assessed liver and blood Vd1+ T cells for
the expression of CD27 and CD45RA surface markers
(Fig. 4D-E); we noted a loss of CD27hi Vd1+ T cells (Fig. 4D) in
intrahepatic cd T cells, consistent with the lower diversity we
observed in liver TCR repertoires than that of peripheral blood.
While CD27lo/ CD45RAhi cells were present in both liver and
blood, we noted the presence of an intrahepatic CD27lo/
CD45RAlo/ Vd1+ T cell population that was present in all livers
Research Article Molecular and Cell BiologyVd2 TCRc repertoires and had very limited shared sequences
between unrelated donors (Fig. S2E).
Consistent with flow cytometry analyses (Fig. 1G-H), Vd
chain usage was dominated by Vd1 (73.96% ±SEM 8.7) and
Vd3 (24.05% ±SEM 9.3) chain usage, with little Vd4, Vd5 and
Vd8 usage observed (Fig. 2E). Despite dominant clonotypes, Vc
chain usage was highly heterogeneous, with all coding Vc
chains utilised across our samples (Fig. 2F). Moreover, no signif-
icant difference was observed in Vd or Vc chain usage between
healthy and diseased samples (Fig. 2E-F), consistent with the
similar diversity metrics observed in diseased and healthy liver
samples. These TCR sequencing data indicate the overwhelming
prevalence of Vd1+ TCR sequences in liver tissue, while confirm-
ing previous findings demonstrating a relative enrichment of
Vd3+ cd T cells in human liver compared to peripheral blood.19
Next, we assessed individual Vd1+ and Vd3+ TCR repertoires for658 Journal of Hepatology 2to varying degrees, but that was found at only very low levels in
peripheral blood (Fig. 4E). The extent of this enrichment in liver
was unaffected by liver disease aetiology (Fig. 4E) or CMV
infection (Fig. S4).
We then explored the clonality of intrahepatic CD27lo/
CD45RAhi and CD27lo/ CD45RAlo/ populations by single-cell
TCR sequencing. In a representative liver sample, sorted intra-
hepatic CD27lo/ CD45RAlo and CD27lo/ CD45RAhi Vd1+ T cell
populations each comprised single prominent, distinct
clonotypes using single-cell sort identities (i.e. CD45RAhi or lo),
allowing the direct alignment of clonotype to phenotype at the
single-cell level (Fig. 5A). Notably, within intrahepatic cd T cells,
both the CD45RAhi and CD45RAlo populations were predomi-
nantly clonally expanded (Fig. 5A; B, left panel). Consistent with
previous findings,16 in blood the CD27hi compartment
(reduced in frequency in liver) was polyclonal, whereas the018 vol. 69 j 654–665
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OF HEPATOLOGYCD27lo/ CD45RAhi compartment was dominated by clonal
expansions (Fig. 5B, right panel); notably the CD27lo/ CD45RAlo
compartment was essentially absent in blood. We then system-
atically examined the relationship between clonotypic and phe-
notypic identity from matched pairs of blood and liver Vd1+ cd T
cells (Fig. 5C). Overall in our paired samples, we identified clono-
types present in both the blood and liver, however importantly
we also identified clonotypes unique to either liver or blood
(Fig. 5C). The phenotype of clonotypes found only in the blood
or shared between blood and liver generally mapped to the
CD27lo/ CD45RAhi compartment found both in blood and liver.
In contrast, the clonotypes present exclusively in the liver
mapped between CD27lo/ CD45RAlo and CD27lo/ CD45RAhi
compartments, with a trend towards a CD27lo/ CD45RAlo phe-
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IL-15 but not IL-7 cytokines (Fig. 6C). We next assessed effector
potential, by analysing intracellular expression of cytolytic
granzyme B and perforin. Intrahepatic CD27lo/ CD45RAhi Vd1+
T cells expressed marked levels of both effector molecules while
CD27lo/ CD45RAlo Vd1+ T cells had much lower expression
(Fig. 6D). Conversely, stimulation of the CD27lo/ CD45RAlo pop-
ulation with PMA and ionomycin produced significantly more of
the pro-inflammatory cytokines IFN-c and TNFa than the
CD27lo/ CD45RAhi population (Fig. 6E). These data suggest that
intrahepatic CD27lo/ CD45RAlo Vd1+ T cells have a more promi-
nent tissue-associated phenotype than that of the CD27lo/
CD45RAhi Vd1+ T cell population, which are more similar to
peripheral blood CD27lo/ CD45RAhi Vd1+ T cells. Moreover,
these two populations possess either enhanced cytolytic
(CD45RAhi) or pro-inflammatory cytokine (CD45RAlo)
responses, suggesting distinct roles in intrahepatic immunity.
Discussion
Tissue-associated T cells are thought to play a critical role in tis-
sue immunosurveillance and homeostasis.28–30 In mice, cd T
cells have been implicated in epithelial homeostasis,31 cuta-
neous wound healing32 and maintenance of gut mucosa,33 and
have been highlighted as innate-like, expressing canonical
TCRs.34 In humans, solid tissues are known to be enriched for
cd T cells but the immunobiology of the T cells present has
remained largely unclear. Recent studies on Vd1+ T cells, the
canonical tissue-associated human cd T cell subset, have
revealed an adaptive biology.16,17 However, these results were
based exclusively on peripheral blood Vd1+ cells, and the
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Fig. 3. Single-cell TCR sequencing reveals clonal focussing in Vd2 cd T
cells. Clonal focussing of intrahepatic (A) Vd1+ and (B) Vd3+ cells determined
Research Article Molecular and Cell Biologywidely by Vd1+ T cells, it was markedly higher on CD27lo/
CD45RAlo Vd1+ T cells and comparable to CD45RAlo CD8+ ab T
cells (Fig. 6A). In keeping with functional tissue retention,
Vd1+ T cells expressed CXCR3 and CXCR6, with expression pre-
dominantly associated with the CD27lo/ CD45RAlo population
(Fig. 6B). In contrast, the endothelial homing receptor CX3CR1
(highly expressed by peripheral blood CD27lo/ CD45RAhi Vd1+
T cells16) was retained on intrahepatic CD27lo/ CD45RAhi cells
but was markedly reduced on CD27lo/ CD45RAlo Vd1+ T cells
(Fig. 6B). Interestingly, intrahepatic CD45RAlo Vd1+ T cells did
not express significantly more CD103 than CD45RAhi Vd1+ T
cells, which contrasts with CD8+ CD45RAlo T cells isolated from
the same livers (Fig. 6B). We next assessed the functionality of
intrahepatic Vd1+ T cell populations by ex vivo stimulation with
recombinant cytokines or by TCR activation. Following TCR
stimulation, intrahepatic Vd1+ T cell populations in general
strongly upregulated the T cell activation marker CD25, with
equivalent responses in CD8+ ab T cells from the same samples,
although Vd1+ T cells from some liver samples responded more
robustly than others. Importantly, intrahepatic CD27lo/
CD45RAlo Vd1+ T cells displayed a greater sensitivity to innate
associated cytokines IL-12 and IL-18, than CD27lo/ CD45RAhi
Vd1+ T cells (Fig. 6C). Notably, peripheral blood CD27lo/
CD45RAhi Vd1+ T cells are unresponsive to IL12/IL-18 stimula-
tion.16 In keeping with a clonally expanded intrahepatic Vd1+
T cell population, significant responses were observed with
by single-cell TCR sequencing analysis of CDR3d. Each colour represents an
individual CDR3d, with clonal sequences labelled beside each chart (from
16–42 single cells per population, as indicated; with each pie chart
representing an independent donor). CDR3, complementarity determining
region 3; TCR, T cell receptor. (This figure appears in colour on the web.)660 Journal of Hepatology 2immunobiology of solid tissue-associated Vd1+ lymphocytes,
often assumed to be innate-like, is of particular interest. We
chose to probe these issues by characterising intrahepatic cd T
cells as a human model system.
We used NGS approaches to show the hepatic Vd2 compart-
ment is comprised of highly clonal, private expansions, based on
complex TCR rearrangements. Importantly these were evident
in both diseased and healthy livers, with no skewing of the
TCR repertoire chain usage observed between the two scenarios.
Moreover, the proportion of Vd2 cd T cells decreased upon
liver inflammation compared with healthy livers, because of
an influx of ab T cells. Therefore, the accumulation of cd T cells
in human liver is not driven by the diseased hepatic microenvi-
ronment present in these patients, and may reflect a response to
other immune challenges such as infection. Of relevance, CMV
infection has recently been highlighted as one of a number of
drivers of Vd2 T cell clonal expansion (specifically of Vd1+ T
cells) in peripheral blood.16,17 Moreover, studies on murine
CMV have highlighted the potential of expanded cd T cell sub-
sets to populate a range of peripheral tissues, including the
liver.35,36 These observations raise the significant possibility
that the expanded clonotypes that contribute so dominantly
to human intrahepatic cd T cells both in normal and diseased
settings have arisen due to previous infections. Consistent with
this, Vd1+ cd T cells were significantly enriched in liver explants
from CMV+ vs. CMV donors. Therefore, CMV represents one
likely driver of Vd1+ infiltration in the liver. However, it is nota-
ble that similar clonotypic focussing and immunophenotypic
profiles of intrahepatic Vd2 T cells were observed in both
CMV+ and CMV individuals, consistent with the idea that the
Vd2 subset can mount tissue-localised responses to multiple
infections. This mirrors the situation with human Vd1+ T cells018 vol. 69 j 654–665
in peripheral blood, where although CMV is linked with an
increased proportion of Vd1+ T cells16,37 and clearly drives clonal
expansions of Vd1+ clonotypes,17 such expansions are com-
monly observed in CMV individuals, suggestive of other infec-
tious drivers.16 While the candidate drivers of intrahepatic Vd2+
T cell expansion would include HCV/HBV, notably we did not
study HCV/HBV-related liver disease, and therefore other non-
CMV/HCV/HBV drivers must exist. In principle, an alternative
to infection representing a main driver of Vd2 clonal expansion
is that intrahepatic Vd2 T cells are populated in the liver during

populations were relatively prevalent in matched blood. Previ-
ously we have shown that CD27hi Vd1+ T cells in peripheral
blood are TCR-diverse and naïve in phenotype. Consistent with
selective exclusion of this clonally diverse CD27hi naïve popula-
tion, liver Vd2 cells lacked CCR7, CD62L and CD27 present on
such naïve populations, and diversity metrics indicated liver
Vd2 T cells displayed an even more focussed repertoire in liver
than in peripheral blood. Furthermore, the phenotype of liver
Vd2 T cells closely matched that of peripheral blood CD27lo/
Vd1+ T cells, and there was substantial clonotypic overlap
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OF HEPATOLOGYdevelopment. However, both their Vd2 chain usage and the
highly complex nature of the intrahepatic Vd2 TCR CDR3
regions would argue against this possibility, since foetal cd TCRs
would be expected to utilise more simple CDR3 sequences and
have also been highlighted as predominantly Vd2+,38 thereby
highlighting post-natal stimuli such as infection as a more likely
underlying driver.
Given previous observations regarding peripheral blood Vd1+
T cells,16 which like those in the liver were frequently highly
clonal and also featured private expansions based on complex
TCR rearrangements, a key question was the extent to which
liver Vd2 cd T cells mirrored those in the blood. Our study pro-
vides compelling evidence that despite the profound link
between the liver and the peripheral circulatory system, there
is a distinct profile of Vd2 cd T cells in each compartment,
indicative of compartmentalisation of certain Vd2 subsets.
Comparison of matched liver and blood samples indicated
the differentiation status of the Vd2 T cell subset was distinct
in each compartment. Strikingly, liver Vd2 T cells were uni-
formly CD27lo/, a phenotype previously linked to a clonally
expanded effector subset present in peripheral blood, and
essentially entirely lacked the CD27hi subset, even when suchJournal of Hepatology 2between these two populations. While we cannot exclude the
possibility that such hepatic CD27lo/ originated in the liver,
these results support the concept that at least some hepatic
CD27lo/ cells may derive from those present in peripheral
blood. Such a scenario would fit an adaptive model whereby
naïve peripheral blood Vd2 CD27hi cells, which express sec-
ondary lymphoid homing markers but are devoid of CX3CR1,
recirculate between blood and lymph, whereas the peripheral
blood CD27lo/ population, which is clonally expanded and
likely antigen-experienced, is capable of accessing solid tissues,
potentially because of increased CX3CR1 expression, and may
also upregulate tissue retention markers following liver
localisation.
A second indication of compartmentalisation was that in
addition to being devoid of CD27hi naïve cells, the hepatic
Vd2 T cell compartment comprised both a CD45RAhi and also
a distinct CD45RAlo subset. By contrast, the peripheral blood
CD27lo/ Vd1+ cells are almost entirely CD45RAhi. Importantly,
CD45RAhi clonotypes overlapped substantially between blood
and liver within individuals. Such cells in the peripheral blood
express a high level of the endothelial homing receptor CX3CR1
as well as increased CD16, low CD27/28, low CD127, and018 vol. 69 j 654–665 661
enhanced levels of adhesion molecules relative to naïve CD27hi
cells.16 While this could suggest capability of homing from
peripheral blood to tissues, alternatively it could imply a vascu-
to peripheral blood, the same analyses of matched blood/liver
samples revealed CD45lo clonotypes were enriched for those
restricted to the liver. In addition, this liver CD45RAlo compart-
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Fig. 5. Intrahepatic Vd1 T cells contain clonotypes both distinct and overlapping with the blood. (A) Clonal focussing of intrahepatic Vd1+ CD27lo/
CD45RAlo (n = 11 single cells) and CD27lo/ CD45RAhi (n = 24 single cells) cells determined by single-cell TCR sequencing analysis of CDR3d. Each colour
represents an individual CDR3d, with clonal amino acid sequences labelled below the chart. Total Vd1+: TCR sequence data was combined with flow cytometry
data to generate the two layered pie, linking clonotype (inner pie chart) to phenotype (outer pie chart). (B) Assessment of clonality by single-cell TCR
sequencing analysis of CD27lo/ CD45RAlo, CD27loCD45RAhi and CD27hi Vd1+ T cells sorted from liver and donor matched blood (n = 8). (C) Comparison of the
relationship between phenotype (outer pie chart) and clonality (inner pie chart) determined by phenotype-linked indexed single-cell TCR sequencing analysis,
in donor matched peripheral blood (upper) and liver (lower) Vd1+ T cells, classified according to clone presence within liver and/or blood compartments. Error
bars indicate mean ± SEM; data analysed by Mann-Whitney U test, ***p <0.001. CDR3, complementarity determining region 3; TCR, T cell receptor. (This figure
appears in colour on the web.)
Research Article Molecular and Cell Biologylar association, as has been suggested for effector memory CD8
T cells,39 which include virus-specific CD8+40 and CD4+41 T cell
subsets. The predominantly sinusoidal localisation of these cells
identified in this study is consistent with this possibility, and
may suggest a role in immunosurveillance at this site, as sug-
gested for NKTs.42 In light of the recent report that Vd1+ clono-
types can expand in response to CMV,17 a virus that infects the
endothelial compartment in vivo, and our observation here that
Vd1+ T cells are enriched in CMV+ vs. CMV liver explants, these
findings suggest this subset may contribute to unconventional T
cell protection of the vascular niche, including within solid tis-
sues, against chronic viral infection. Moreover, the observation
CMV serostatus correlates with an enhanced proportion of
intrahepatic Vd1+ T cells but not with a disturbed CD45RAhi
vs. CD45RAlo Vd1+ ratio might suggest the potential within both
phenotypic sub-compartments to respond to CMV.
In contrast to CD45RAhi clonotypes and consistent with a
reduced frequency of CD45RAhi Vd2 cells in liver compared662 Journal of Hepatology 2ment frequently contained clonal expansions. These cells
demonstrate striking phenotypic correlation with liver-
resident lymphocytes identified in previous studies, including
enhanced expression of CD69, CXCR3 and CXCR6, which has
been noted in liver-resident NK populations43,44 and CD8+ ab
populations.25 CD27lo/ CD45RAlo Vd2 T cells may therefore
represent a liver-resident subset, although conceivably they
may be able to access other solid tissues. Of note, CD45RAlo
Vd1+ T cells exhibited considerably lower expression of CD103
relative to their CD8+ counterparts, suggesting other mecha-
nisms may underly their tissue retention. The origin of this sub-
set is unclear. One possibility is that it originates from a subset
of blood CD45RA+ cells that alter phenotype once in tissues and
are retained there, perhaps following activation in the hepatic
microenvironment. This route of generation is supported by
our detection of liver-restricted clonotypes in both the
CD45RAlo and CD45RAhi compartments. In addition, it is possi-
ble they may be locally generated. Moreover, recent reports018 vol. 69 j 654–665
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OF HEPATOLOGYhighlight that a liver-resident phenotype can be induced in
CD8+ ab T cells via IL-15 followed by TGF-b signalling,25 and
based on the parallels between Vd1+ and CD8+ ab T cells identi-
fied in this study, a similar mechanism may be at work here.
Our results also highlight that hepatic cd T cells are function-
ally distinct from equivalent subsets in peripheral blood. While
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Fig. 6. Intrahepatic Vd1+ T cells segregate into cytokine producing and cyto
of CD69 surface expression by CD45RAlo (orange) and CD45RAhi (grey) intrahe
histograms and summary data for CXCR3, CXCR6 and CX3CR1 surface expressi
and summary data from sorted intrahepatic CD3+ T cells were incubated with in
and CD45RAhi (grey) Vd1+ T cells were then assessed for the upregulation of t
summary data for intracellular granzyme B and perforin expression by CD45RA
Representative flow cytometry plot and summary data of intrahepatic CD3+
intracellular IFNc and TNFa in CD45RAlo (orange) and CD45RAhi (grey) Vd1+ an
Wallis ANOVA with Dunn’s post-test comparisons, n.s. p >0.05, *p <0.05, **p <0.
and normal liver no significant differences were observed between different i
liver disease; IFN, interferon; NASH, non-alcoholic steatohepatitis; PSC, primary
in colour on the web.)still responsive to TCR stimulation/co-stimulation, compared to
blood Vd2 T cells they displayed markedly increased respon-
siveness to IL-12/IL-18 in line with CD8+ T cells isolated from
the same tissue. This responsiveness extended to the liver-
restricted CD45RAlo subset, which appeared to display
enhanced production of pro-inflammatory cytokines relative
to CD45RAhi cells. These observations suggest CD45RAhi and
CD45RAlo subsets may have different roles, the former more
vascular focussed and cytotoxic, the latter an immunoregula-
tory tissue-associated subset more focussed on cytokine pro-
duction and potential induction of a wider T cell response to
stress challenges. It is unclear if these distinct features stemJournal of Hepatology 2Intrahepatic Vδ1+  T cells
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%directly from the nature of the clonotypes present and their
antigenic targets, or whether they reflect the influence of hep-
atic microenvironmental factors that may also influence intra-
hepatic retention.45
Importantly, we note several limitations of our study. Firstly,
all diseased samples were derived from end-stage liver disease.
While the closely matched clonotypic focussing and
immunophenotypic profiles present in normal tissue would pre-
dict similar profiles at earlier disease stages, we cannot exclude
the possibility that disease stage influences the nature of the
intrahepatic cd T cell population, and use of biopsy material
from early disease stages with longitudinal follow-up could be
an interesting avenue of future investigation. Secondly, while
we examined several disease pathologies, these were predomi-
nantly restricted to fatty/alcoholic liver disease (ALD, NAFLD) or
autoimmune liver disease (AIH, PBC, or PSC). While HCV/HBV+
liver samples showed similar frequencies of cd T cells, we did
not study cd T cell immunophenotype or clonotypic focussing
icated medium, cytokines or anti-CD3/CD28 beads for 72 h. CD45RAlo (orange)
e T cell activation marker CD25 (n = 5–6). (D) Representative histograms and
(orange) and CD45RAhi (grey) intrahepatic Vd1+ and CD8+ T cells (n = 5–6). (E)
T cells stimulated with PMA/Ionomycin and assessed for the production of
CD8+ cells (n = 6). Error bars indicate mean ± SEM; data analysed by Kruskal-
and ***p <0.001. (A–E) Disease aetiologies analysed included ALD, NASH, PSC,
ividual disease groups in any of the comparisons highlighted. ALD, alcoholic
clerosing cholangitis; TNFa, tumour necrosis factor alpha. (This figure appears018 vol. 69 j 654–665 663
Research Article Molecular and Cell Biologyin such samples and cannot therefore exclude the possibility
that HCV/HBV infection may drive development of distinct
intrahepatic cd T cell profiles47 or clonality, although we
hypothesise they would follow broadly similar principles to
those observed in this study; moreover, while we did not
observe differences between the different disease types we
did analyse, conceivably with larger samples sizes differences
may have emerged, for example in the extent of cd TCR clono-
typic focussing or cd T cell phenotypes. Finally, a comparison
of the data presented here with cd T cell clonotype and
immunophenotype profiles in other solid tissues, including
during chronic inflammation, would shed light on tissue-
specific cd T cell responses.
Our study establishes that in humans, clonally expanded cd T
cell effector subsets can be selectively deployed to at least some
solid tissues, including the liver, thereby providing ongoing
immune surveillance against previously encountered infectious
or non-infectious challenges, with CMV infection one likely dri-
ver of Vd1+ T cell intrahepatic infiltration. Importantly, both
Vd1+ and Vd3+ intrahepatic T cell compartments displayed
clonotypic expansion and a CD45RAlo subset, suggesting their
immunobiology may be closely aligned. Moreover, the finding
that intrahepatic cd T cell subsets can be phenotypically, clono-
typically and functionally distinct from those in peripheral
blood suggests distinct contributions to intrahepatic immune
responses, and provides a basis for future investigation of
human tissue-resident cd T cell populations. Notably, cd T cells
are of increasing therapeutic interest, due partly to their poten-
tial to mount either anti-tumour,47–49 or alternatively immuno-
suppressive50 responses, but also their MHC-unrestricted
recognition of target cells, which raises the prospect of broad
applicability of cd T cell-based therapies in patient cohorts.
Our finding that there appears to be selective recruitment of
cd T cell subsets of an effector phenotype into the hepatic pool
may inform design of cd T cellular therapies that rely on admin-
istration/expansion of systemic cd T cells. Secondly, the finding
that a number of distinct differentiation states exist within the
Vd1+ compartment (including naïve, circulating effector, tissue-
resident effector) indicates a degree of plasticity that could be
investigated further and potentially exploited therapeutically,
either to increase immunosuppressive functionality during
inflammatory liver disease, or for improved anti-tumour effec-
tor function in liver cancer. Finally, our finding that CMV infec-
tion represents one likely factor driving infiltration of
potentially highly inflammatory Vd1+ T cells into the liver could
have clinical relevance in chronic liver disease and CMV-
associated hepatitis. Specifically, future studies correlating
CMV titres with biomarkers of liver damage and with Vd1+ cd
T cell frequency may shed light on whether the cd T cell
response to CMV infection impacts the severity of chronic liver
disease.
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